Sohn, J., Lim, S., Jeong, J. H., Lee, K., Lee, K. S., Moon, Y. W., Kim, J., Lee, J., Kim, H. J., Chae, Y. S., Kim, J. H., Lee, S., Park, I. H., Kang, S. Y., Park, K., Cho, E. K., Kim, H. J., Kim, G. M., Kim, M. H., Kim, K. H. (2025). Phase IB and II study of ribociclib with trastuzumab plus endocrine therapy in HR+/HER2+ advanced breast cancer patients: Korean Cancer Study Group BR 18-2 MINI trial.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2025.43.16_suppl.1016